Liposomal curcumin inhibits Lewis lung cancer growth primarily through inhibition of angiogenesis

Oncology Letters

Volumn 4, Issue 1, 2012, Pages 107-112

  Wang, Liqiang ^a   Zhang, Jing ^a   Cai, Lulu ^a   Wen, Jing ^a   Shi, Huashan ^a   Li, Dan ^a   Guo, Fuchun ^a   Wang, Yongsheng ^a  

^a SICHUAN UNIVERSITY   (China)

Author keywords

Angiogenesis; Anti angiogenic agents; Liposomal curcumin; Lung cancer

Indexed keywords

ALGINIC ACID; CD31 ANTIGEN; CURCUMIN; LIPOSOME;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIANGIOGENIC ACTIVITY; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER GROWTH; CANCER INHIBITION; CELL CYCLE ARREST; CELL PROLIFERATION; CONTROLLED STUDY; EMBRYO; ENCAPSULATION; ENDOTHELIUM CELL; FEMALE; FLOW CYTOMETRY; IMMUNOHISTOCHEMISTRY; LIPOSOMAL DELIVERY; LUNG CANCER; NONHUMAN; ZEBRA FISH;

EID: 84861317460     PISSN: 17921074     EISSN: 17921082     Source Type: Journal    
DOI: 10.3892/ol.2012.686     Document Type: Article

References (24)

1. Pongrakhananon V, Nimmannit U, Luanpitpong S, Rojanasakul Y and Chanvorachote P: Curcumin sensitizes non-small cell lung cancer cell anoikis through reactive oxygen species-mediated Bcl-2 downregulation. Apoptosis 15: 574-585, 2010.
2. Bharti AC, Donato N, Singh S and Aggarwal BB: Curcumin (diferuloylmethane) down-regulates the constitutive activation of nuclear factor-kappa B and IkappaBalpha kinase in human multiple myeloma cells, leading to suppression of proliferation and induction of apoptosis. Blood 101: 1053-1062, 2003.
3. O'Sullivan-Coyne G, O'Sullivan GC, O'Donovan TR, Piwocka K and McKenna SL: Curcumin induces apoptosis-independent death in oesophageal cancer cells. Br J Cancer 101: 1585-1595, 2009.
4. Bhandarkar SS and Arbiser JL: Curcumin as an inhibitor of angiogenesis. Adv Exp Med Biol 595: 185-195, 2007.
5. Cheng AL, Hsu CH, Lin JK, et al: Phase I clinical trial of curcumin, a chemopreventive agent, in patients with high-risk or pre-malignant lesions. Anticancer Res 21: 2895-2900, 2001.
6. Dhillon N, Aggarwal BB, Newman RA, et al: Phase II trial of curcumin in patients with advanced pancreatic cancer. Clin Cancer Res 14: 4491-4499, 2008.
7. Takahashi M, Uechi S, Takara K, Asikin Y and Wada K: Evaluation of an oral carrier system in rats: bioavailability and antioxidant properties of liposome-encapsulated curcumin. J Agric Food Chem 57: 9141-9146, 2009.
8. Allen TM and Cullis PR: Drug delivery systems: entering the mainstream. Science 303: 1818-1822, 2004.
9. Bejjani RA, Jeanny JC, Bochot A and Behar-Cohen F: The use of liposomes as intravitreal drug delivery system. J Fr Ophtalmol 26: 981-985, 2003.(In French).
10. Carmeliet P and Jain RK: Angiogenesis in cancer and other diseases. Nature 407: 249-257, 2000.
11. Gasparini G, Longo R, Toi M and Ferrara N: Angiogenic inhibitors: a new therapeutic strategy in oncology. Nat Clin Pract Oncol 2: 562-577, 2005.
12. Bai RZ, Wu Y, Liu Q, et al: Suppression of lung cancer in murine model: treated by combination of recombinant human endostsatin adenovirus with low-dose cisplatin. J Exp Clin Cancer Res 28: 31, 2009.
13. He QM: Inhibition of tumor growth with a vaccine based on xenogeneic homologous fibroblast growth factor receptor-1 in mice. J Biol Chem 278: 21831-21836, 2003.
14. Zheng M, Ekmekcioglu S, Walch ET, Tang CH and Grimm EA: Inhibition of nuclear factor-kappaB and nitric oxide by curcumin induces G2/M cell cycle arrest and apoptosis in human melanoma cells. Melanoma Res 14: 165-171, 2004.
15. Liao S, Xia J, Chen Z, et al: Inhibitory effect of curcumin on oral carcinoma CAL-27 cells via suppression of Notch-1 and NF-κB signaling pathways. J Cell Biochem 112: 1055-1065, 2011.
16. Tabruyn SP and Griffioen AW: A new role for NF-κB in angiogenesis inhibition. Cell Death Differ 14: 1393-1397, 2007.
17. Wang WZ, Cheng J, Luo J and Zhuang SM: Abrogation of G2/M arrest sensitizes curcumin-resistant hepatoma cells to apoptosis. FEBS Lett 582: 2689-2695, 2008.
18. Yadav VR and Aggarwal BB: Curcumin: a component of the golden spice, targets multiple angiogenic pathways. Cancer Biol Ther 11: 236-241, 2011.
19. Wang W, Bernard K, Li G and Kirk KL: Curcumin opens cystic fibrosis transmembrane conductance regulator channels by a novel mechanism that requires neither ATP binding nor dimerization of the nucleotide-binding domains. J Biol Chem 282: 4533-4544, 2007.
20. Thangapazham RL, Puri A, Tele S, Blumenthal R and Maheshwari RK: Evaluation of a nanotechnology-based carrier for delivery of curcumin in prostate cancer cells. Int J Oncol 32: 1119-1123, 2008.
21. Wang D, Veena MS, Stevenson K, et al: Liposome-encapsulated curcumin suppresses growth of head and neck squamous cell carcinoma in vitro and in xenografts through the inhibition of nuclear factor kappaB by an AKT-independent pathway. Clin Cancer Res 14: 6228-6236, 2008.
22. Mach CM, Mathew L, Mosley SA, Kurzrock R and Smith JA: Determination of minimum effective dose and optimal dosing schedule for liposomal curcumin in a xenograft human pancreatic cancer model. Anticancer Res 29: 1895-1899, 2009.
23. Sreekanth CN, Bava SV, Sreekumar E and Anto RJ: Molecular evidences for the chemosensitizing efficacy of liposomal curcumin in paclitaxel chemotherapy in mouse models of cervical cancer. Oncogene 30: 3139-3152, 2011.
24. Ganiger S, Malleshappa HN, Krishnappa H, Rajashekhar G, Ramakrishna Rao V and Sullivan F: A two generation reproductive toxicity study with curcumin, turmeric yellow, in Wistar rats. Food Chem Toxicol 45: 64-69, 2007.